A framework for modelling whole-lung and regional transfer factor of the lung for carbon monoxide using hyperpolarised xenon-129 lung magnetic resonance imaging.

Publication date: Jan 01, 2025

Pulmonary gas exchange is assessed by the transfer factor of the lungs (T ) for carbon monoxide (T ), and can also be measured with inhaled xenon-129 (Xe) magnetic resonance imaging (MRI). A model has been proposed to estimate T from Xe MRI metrics, but this approach has not been fully validated and does not utilise the spatial information provided by three-dimensional Xe MRI. Three models for predicting T from Xe MRI metrics were compared: 1) a previously-published physiology-based model, 2) multivariable linear regression and 3) random forest regression. Models were trained on data from 150 patients with asthma and/or COPD. The random forest model was applied voxel-wise to Xe images to yield regional T maps. Coefficients of the physiological model were found to differ from previously reported values. All models had good prediction accuracy with small mean absolute error (MAE): 1) 1. 24+/-0. 15 mmol.min.kPa, 2) 1. 01+/-0. 06 mmol.min.kPa, 3) 0. 995+/-0. 129 mmol.min.kPa. The random forest model performed well when applied to a validation group of post-COVID-19 patients and healthy volunteers (MAE=0. 840 mmol.min.kPa), suggesting good generalisability. The feasibility of producing regional maps of predicted T was demonstrated and the whole-lung sum of the T maps agreed with measured T (MAE=1. 18 mmol.min.kPa). The best prediction of T from Xe MRI metrics was with a random forest regression framework. Applying this model on a voxel-wise level to create parametric T maps provides a useful tool for regional visualisation and clinical interpretation of Xe gas exchange MRI.

Open Access PDF

Concepts Keywords
15mmolminkpa Carbon
Forest Factor
Mri Forest
Pulmonary Imaging
Volunteers Lung
Maps
Metrics
Models
Monoxide
Mri
Random
Regional
Regression
Transfer
Xenon

Semantics

Type Source Name
drug DRUGBANK Carbon monoxide
disease MESH asthma
pathway KEGG Asthma
disease MESH COPD
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)